From: RGS2 and female common diseases: a guard of women’s health
Disease | RGS protein | Mechanisms | References |
---|---|---|---|
Ovarian carcinoma | RGS2 RGS5 RGS10 RGS17 | Accumulation of DNMT1 and class I HDACs Histone modifications and DNA methylation To regulate PI3K/AKT survival pathway | |
Hysteromyom | RGS2 RGS6 | To reduce the endogenous levels of progesterone | |
Gestational hypertension | RGS2 | To restrain Gαq signaling in vascular smooth muscle To regulate Gαi/o signaling in the vascular endothelium To alter Gαs signaling | |
Preeclampsia | RGS2 | SNP (rs4606) is correlated with an increased risk in PE development To activate Gq-coupled AT1 receptors, ANG II can trigger vasoconstriction To regulate trophoblast cells epithelial-mesenchymal transition Regulated by hypoxia that contributes to PE | |
Postpartum Depression | RGS2 | Knockdown of Rgs2 reinforces the 5-HT levels in hippocampal CA1 neurons Silencing of Rgs2 accelerates the cAMP pathway activation | |
Breast cancer | RGS2 RGS16 | miR-183-5p promotes BC progression through RGS2 DNA methylation by microdeletions in the RGS16 promoter region (1q25.3) | |
Pulmonary Hypoplasia | RGS2 | To repress signals such as duration and amplitude To reduce thrombin-induced intracellular Ca2 + signaling |